A detailed history of Sg Americas Securities, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Sg Americas Securities, LLC holds 628,510 shares of TEVA stock, worth $11 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
628,510
Previous 651,484 3.53%
Holding current value
$11 Million
Previous $10.6 Million 6.98%
% of portfolio
0.04%
Previous 0.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

SELL
$15.81 - $18.96 $363,218 - $435,587
-22,974 Reduced 3.53%
628,510 $11.3 Million
Q2 2024

Jul 12, 2024

BUY
$12.78 - $17.4 $524,964 - $714,739
41,077 Added 6.73%
651,484 $10.6 Million
Q1 2024

May 06, 2024

BUY
$10.67 - $14.43 $699,194 - $945,583
65,529 Added 12.03%
610,407 $8.61 Million
Q4 2023

Jan 12, 2024

BUY
$8.12 - $10.63 $1.06 Million - $1.39 Million
131,043 Added 31.67%
544,878 $5.69 Million
Q3 2023

Oct 13, 2023

BUY
$7.48 - $10.7 $1.59 Million - $2.28 Million
212,761 Added 105.81%
413,835 $4.22 Million
Q2 2023

Jul 10, 2023

BUY
$7.2 - $9.47 $202,327 - $266,116
28,101 Added 16.25%
201,074 $1.51 Million
Q1 2023

Apr 28, 2023

BUY
$8.36 - $11.37 $116,120 - $157,929
13,890 Added 8.73%
172,973 $1.53 Million
Q4 2022

Feb 02, 2023

BUY
$7.95 - $9.48 $133,011 - $158,609
16,731 Added 11.75%
159,083 $1.45 Million
Q3 2022

Oct 31, 2022

SELL
$6.86 - $11.95 $2.65 Million - $4.62 Million
-386,861 Reduced 73.1%
142,352 $1.15 Million
Q2 2022

Jul 29, 2022

SELL
$7.38 - $10.4 $193,444 - $272,604
-26,212 Reduced 4.72%
529,213 $3.98 Million
Q1 2022

Apr 29, 2022

SELL
$7.33 - $9.39 $2.06 Million - $2.64 Million
-280,872 Reduced 33.59%
555,425 $5.22 Million
Q4 2021

Feb 07, 2022

SELL
$7.9 - $10.19 $325,298 - $419,593
-41,177 Reduced 4.69%
836,297 $6.7 Million
Q3 2021

Nov 01, 2021

SELL
$8.38 - $10.18 $3.35 Million - $4.07 Million
-399,704 Reduced 31.3%
877,474 $8.55 Million
Q2 2021

Aug 12, 2021

SELL
$9.9 - $11.56 $1.72 Million - $2.01 Million
-173,849 Reduced 11.98%
1,277,178 $12.6 Million
Q1 2021

May 13, 2021

BUY
$10.34 - $12.81 $2.59 Million - $3.21 Million
250,376 Added 20.85%
1,451,027 $16.7 Million
Q4 2020

Feb 04, 2021

BUY
$8.61 - $11.04 $2.14 Million - $2.74 Million
248,174 Added 26.06%
1,200,651 $11.6 Million
Q3 2020

Nov 09, 2020

BUY
$8.57 - $12.69 $4.84 Million - $7.17 Million
565,238 Added 145.97%
952,477 $8.58 Million
Q2 2020

Jul 20, 2020

BUY
$8.12 - $13.12 $1.07 Million - $1.72 Million
131,450 Added 51.39%
387,239 $4.78 Million
Q1 2020

Apr 30, 2020

SELL
$6.69 - $13.45 $4.84 Million - $9.73 Million
-723,383 Reduced 73.88%
255,789 $2.3 Million
Q4 2019

Jan 28, 2020

BUY
$6.53 - $10.72 $3.98 Million - $6.53 Million
609,480 Added 164.86%
979,172 $9.6 Million
Q3 2019

Nov 04, 2019

SELL
$6.16 - $9.6 $590,928 - $920,928
-95,930 Reduced 20.6%
369,692 $2.54 Million
Q2 2019

Jul 29, 2019

BUY
$8.12 - $15.72 $2.88 Million - $5.57 Million
354,145 Added 317.68%
465,622 $4.3 Million
Q1 2019

Apr 29, 2019

SELL
$15.58 - $20.01 $8.19 Million - $10.5 Million
-525,922 Reduced 82.51%
111,477 $1.75 Million
Q4 2018

Feb 01, 2019

BUY
$14.59 - $23.84 $7.55 Million - $12.3 Million
517,417 Added 431.25%
637,399 $9.83 Million
Q3 2018

Nov 06, 2018

SELL
$21.06 - $25.65 $2.97 Million - $3.62 Million
-141,118 Reduced 54.05%
119,982 $2.58 Million
Q2 2018

Aug 07, 2018

BUY
$16.77 - $24.71 $2.49 Million - $3.67 Million
148,324 Added 131.52%
261,100 $6.35 Million
Q1 2018

May 03, 2018

BUY
$16.68 - $22.07 $1.88 Million - $2.49 Million
112,776 New
112,776 $1.93 Million
Q4 2017

Jan 24, 2018

SELL
$11.23 - $19.1 $6.72 Million - $11.4 Million
-598,665 Closed
0 $0
Q3 2017

Nov 07, 2017

BUY
$15.41 - $32.17 $9.23 Million - $19.3 Million
598,665
598,665 $10.5 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.